Home・Список акций・Design Therapeutics Inc

Design Therapeutics Inc

Закрыт

10.14 5.3

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

10.11

Макс.

10.26

Ключевые показатели
By Trading Economics
Доход	-2.5M -20M
Прибыль на акцию	-0.32
Сотрудники	55
EBITDA	-4.5M -22M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+113.03% upside

Дивиденды
By Acuity
Следующий отчет о доходах	10 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-107M 635M
Предыдущая цена открытия	4.84
Предыдущая цена закрытия	10.14

Design Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 нояб. 2026 г., 22:42 UTC

UK Retail Sales Monitor Set for Release Amid Cautious Sentiment and Mixed Economic Signals

7 нояб. 2026 г., 22:42 UTC

Mexico's Inflation Rate YoY Expected to Rise Ahead of November 9 Release, Heightening Concerns Over Persistent Price Pressures and Potential Monetary Policy Adjustments.

7 нояб. 2026 г., 22:11 UTC

Mexico's Upcoming Inflation Rate Release on November 9, 2026, Sparks Caution Amid Global Economic Concerns.

7 нояб. 2026 г., 22:11 UTC

Japan's Current Account Surplus Forecasted at JPY 3.35 Trillion Amidst Cautious Market Sentiment Following Nikkei Index Plunge

7 нояб. 2026 г., 22:01 UTC

Spanish Consumer Confidence Index Release on November 10, 2026, Amid Rising Concerns Over Geopolitical Tensions and Inflationary Pressures.

7 нояб. 2026 г., 21:52 UTC

Japan's Household Spending Expected to Decline 3.1% YoY Amid Economic Challenges and Market Skepticism

7 нояб. 2026 г., 21:52 UTC

Australia's Westpac Consumer Confidence Index set for release on November 9, amid global inflation concerns and tech market volatility.

7 нояб. 2026 г., 21:52 UTC

Australia's Westpac Consumer Confidence Index set for release amid global market volatility and cautious sentiment ahead of key economic data.

7 нояб. 2026 г., 21:52 UTC

Japan's Household Spending MoM data for September set to release on November 9, with a modest forecast increase of 0.3% amid cautious market sentiment and recent declines in the Nikkei index.

7 нояб. 2026 г., 21:52 UTC

UK GDP 3-Month Average Data Release on November 12 Sparks Cautious Optimism Amid Economic Uncertainties.

7 нояб. 2026 г., 21:43 UTC

India's Inflation Rate Expected to Rise to 5.93% in October Amidst Geopolitical Tensions and Positive Equity Market Sentiment

7 нояб. 2026 г., 21:43 UTC

South Korea's October 2026 unemployment rate release on November 10 expected to reflect ongoing positive employment trends amid global market volatility.

7 нояб. 2026 г., 21:33 UTC

Euro Area Expected to Report €4.5 Billion Trade Deficit Amid Weak Retail Sales and Rising Inflation Concerns

7 нояб. 2026 г., 21:33 UTC

Euro Area Employment Change Report Forecasts 0.2% Increase Amid Global Labor Market Optimism and Inflation Concerns

7 нояб. 2026 г., 21:23 UTC

Brazil's Central Bank to Provide Key Insights on Interest Rates Amid Global Economic Pressures in Upcoming November 9 Readout.

7 нояб. 2026 г., 21:03 UTC

API Crude Oil Stock Change Report on November 10 Expected Amid Geopolitical Tensions and Volatile WTI Prices at $90 per Barrel.

7 нояб. 2026 г., 20:41 UTC

The CHF/JPY currency pair remains stable near the upper end of its one-month trading range, following Friday's strong U.S. non-farm payroll report.

7 нояб. 2026 г., 20:41 UTC

The EUR/SEK currency pair is roughly flat since Friday's close, amid speculation about potential interest rate hikes following recent U.S. labor market data.

7 нояб. 2026 г., 20:41 UTC

GBP/CAD remained roughly flat over the weekend, positioned near the upper end of its one-month trading range amid speculation of potential Fed interest rate hikes.

7 нояб. 2026 г., 20:41 UTC

The EUR/JPY currency pair has seen a slight increase since Friday's close, remaining stable during the weekend market closure.

7 нояб. 2026 г., 20:41 UTC

The EUR/NZD currency pair is lower since Friday's close, amid speculation of potential U.S. interest rate hikes following strong labor market data.

7 нояб. 2026 г., 20:41 UTC

Macro News

The IBEX 35 Index is declining during after-market hours amid regulatory concerns in the pharmaceutical sector and fears of tighter AI regulations.

7 нояб. 2026 г., 20:33 UTC

China's Q3 2026 Current Account Release Expected to Show Continued Strong Surplus Amid Positive Trade Dynamics

7 нояб. 2026 г., 20:33 UTC

Italy's Balance of Trade data set for November 13 reveals a forecasted surplus of €1.85 billion amid cautious market sentiment and concerns over rising energy costs impacting trade dynamics.

7 нояб. 2026 г., 20:03 UTC

South Africa's Q3 2026 Unemployment Rate Release on November 10 Expected Amidst High Rates and Global Job Market Concerns.

7 нояб. 2026 г., 19:53 UTC

Italy's Industrial Production Expected to Grow 0.7% MoM Amid Mixed European Economic Sentiment Ahead of November Release

7 нояб. 2026 г., 19:33 UTC

UK Q3 2026 GDP Growth Rate Release on November 12 Expected at 0.7% Amid Investor Caution Over Geopolitical Uncertainties and Inflationary Pressures.

7 нояб. 2026 г., 19:33 UTC

UK Goods Trade Balance Expected to Widen Deficit to -19.2 Billion GBP Amid Economic and Geopolitical Pressures

7 нояб. 2026 г., 19:33 UTC

UK Monthly GDP MoM Release on November 12 Forecasts No Growth Amid Cautious Optimism and Inflation Concerns.

7 нояб. 2026 г., 19:33 UTC

UK's Non-EU Goods Trade Balance Data Set for Release on November 12, Expected to Reflect International Trade Trends Amid Cautious Market Sentiment.

Сравнение c конкурентами

Изменение цены

Design Therapeutics Inc Прогноз

Целевая цена

By TipRanks

113.03% рост

Прогноз на 12 месяцев

Средняя 21.75 USD 113.03%

Максимум 26 USD

Минимум 19 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Design Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

Покупка

Удержание

Продажа

Основано на мнении 4 аналитиков, присваивавших рейтинги акциям Design Therapeutics Inc – Данные за последние 3 месяца.

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.